X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Trades Flat; IT, Pharma Stocks Rally
Fri, 15 Jun 12:30 pm | Parth Parekh, TM Team

After opening the day flat share markets in India are trading on a dull note and are presently trading below the dotted line. Sectoral indices are trading on a mixed note, with stocks in the IT sector and stocks in the pharma sector witnessing maximum buying interest.

The BSE Sensex is trading down by 60 points (down 0.2%) and the NSE Nifty is trading down by 12 points (down 0.1%). Meanwhile, the BSE Mid Cap index is trading down by 0.3%, while the BSE Small Cap index is trading down by 0.2%. The rupee is trading at 68.01 to the US$.

In news from stocks in the pharma sector. Alembic Pharma share price is among top gainers today as the company received an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA).

The company received the establishment inspection report (EIR) for its for its formulation facility in Panelav, Gujarat indicating a closure of inspection.

As per USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspection findings.

The USFDA carried out inspection of the company's Panelav facilty from 12-20 March.

--- Advertisement ---
A Method That Doesn't Take YEARS To Grow Investors' Money…

The fact is, most stock market strategies take YEARS to grow investors' money.

But what if a person needs the returns fast for some reason?

A method revealed by research analyst, Apurva Sheth, has the potential to generate returns in a fairly short time. And that too, from some of the best companies in the market.

Yes! To find out all about that method, just click here…
------------------------------

At the time of writing, Alembic Pharma share price was trading up by 3%.

Indian pharma companies catering to the US markets are breathing a sigh of relief. After being adversely affected by import bans and the suspension of new drug approvals from manufacturing facilities in the past three years, there has been a sharp pick-up in new drug approvals in FY17.

With an aim to lower the overall healthcare costs in the country, the US Food and Drug Administration (FDA) approved a record 763 generic drugs for the financial year ending 30th September. As per Mint Analysis, Indian pharma companies received 295 approvals accounting for 40% of the overall approvals during the year.

Generic Drug Approvals Hit the Roof

Even the total filings of abbreviated new drug applications (ANDAs) for generic drugs rose to 1,292 in FY17 from 852 in the previous year. While, faster approvals expedite the commercialisation of product pipelines of domestic pharma companies spurring growth. At the same time however, it has raised the intensity of competition resulting in pricing pressures. The price erosion has been further compounded by a consolidation among US distributors and the decline in the number of products going off-patent over the past few years.

In other words, acceleration in generic drug approvals is like a double-edged sword. The growth boost can be quickly offset by the ensuing pricing pressures. Pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market.

Therefore, despite a lot of pessimism surrounding pharma stocks on regulatory uncertainty, we have stocks in open positions in StockSelect and have remained bullish on pharma stocks in our long term service, ValuePro.

Moving on to news from stocks in the IT sector. Wipro share price was among most active stocks today after the IT major won multiple contracts.

Wipro announced that it signed tow multi-year business deals, one with Nokia and another with LATAM Cargo, part of Latin America's LATAM Airlines Group.

The Nokia deal would be for the design and digitalisation of Nokia's sales order operations, while the deal with LATAM was for cargo management.

However, Wipro did not provide any financial details about both the contracts.

Wipro said that it be applying robotics process automation (RPA) to enable a hyper-automated supply chain, which will be lean, agile and have the flexibility to meet the customer's current business challenges as well as keep pace with their future requirements.

During the financial year 2017-18, the BSE Sensex delivered a return of about 11%. Blame the market correction that started in February for the modest returns.

However, the BSE IT index gained over 19% during the same period. Now, that's a significant outperformance. If you were holding some solid IT stocks last year, you have most likely fared better than the Sensex.

But last year, the markets were not as optimistic on the sector as they are now.

Look at the chart...

During the first half of 2017-18, the IT sector was among the underperformers, and it was lagging way behind the Sensex.

During the first half of 2017-18, the IT sector was among the underperformers, and it was lagging way behind the Sensex. In fact, until October 2017, the index was still hovering near levels seen in April 2017.

But once the mood of the market changed, the IT index not only recovered, but went on to outperform the Sensex.

In Ankit Shah's (Research Analyst) premium newsletter Insider, the IT sector was his top pick since launch of the service in July 2017.

Here's Ankit discussing what gave him the foresight to recommend so many promising IT stocks.

  • Last year when I had discussions with my fundamentals-based research team, I got a clear sense that the uncertainty and negativity surrounding the IT sector -- the H1-B visa problem, the global slowdown concerns, strengthening of the Indian rupee, high attrition rates, etc. -- was blown out of proportion. There was a good contrarian opportunity to buy 'uncertainty' when the markets were fearful of IT stocks.

    Like I said earlier, it is during moments of 'uncertainty' that lucrative investment opportunities are created.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Trades Flat; IT, Pharma Stocks Rally". Click here!

  

Stock Market Updates

LAKSHMI MACHINE Surges by 6%; BSE CAPITAL GOODS Index Up 0.9% (Today's Market)

Nov 13, 2018 02:55 PM

LAKSHMI MACHINE share price has surged by 6% and its current market price is Rs 6,150. The BSE CAPITAL GOODS is up by 0.9%. The top gainers in the BSE CAPITAL GOODS Index is LAKSHMI MACHINE (up 5.5%). The top losers are THERMAX LTD (down 0.1%) and AIA ENGINEERING (down 0.2%).

ASHOKA BUILDCON Surges by 11%; BSE REALTY Index Down 0.6% (Today's Market)

Nov 13, 2018 02:39 PM

ASHOKA BUILDCON share price has surged by 11% and its current market price is Rs 138. The BSE REALTY is down by 0.6%. The top gainers in the BSE REALTY Index is ASHOKA BUILDCON (up 10.7%). The top losers are PHOENIX MILL (down 0.1%) and DLF LTD (down 0.1%).

NCC LTD Surges by 5%; BSE REALTY Index Down 0.8% (Today's Market)

Nov 13, 2018 02:21 PM

NCC LTD share price has surged by 5% and its current market price is Rs 87. The BSE REALTY is down by 0.8%. The top gainers in the BSE REALTY Index is NCC LTD (up 5.1%). The top losers are PHOENIX MILL (down 0.1%) and DLF LTD (down 0.6%).

ASHOKA BUILDCON Surges by 6%; BSE REALTY Index Down 0.8% (Today's Market)

Nov 13, 2018 02:13 PM

ASHOKA BUILDCON share price has surged by 6% and its current market price is Rs 130. The BSE REALTY is down by 0.8%. The top gainers in the BSE REALTY Index is ASHOKA BUILDCON (up 5.7%). The top losers are OMAXE LTD and PHOENIX MILL (down 0.1%).

ALLAHABAD BANK Plunges by 11%; BSE BANKEX Index Up 0.5% (Today's Market)

Nov 13, 2018 02:13 PM

ALLAHABAD BANK share price has plunged by 11% and its current market price is Rs 43. The BSE BANKEX is up by 0.5%. The top gainers in the BSE BANKEX Index are AXIS BANK (up 1.3%) and ICICI BANK (up 1.1%). The top losers is ALLAHABAD BANK (down 10.6%)..

Indian Share Markets Trade Flat; Tata Motors & Sun Pharma Top Losers (Today's Market)

Nov 13, 2018 12:30 pm

The BSE Sensex is trading up by 76 points, while the NSE Nifty is trading up by 26 points.

View More Indian Share Market News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Nov 13, 2018 (Close)

MARKET STATS